TY  - BOOK
AU  - Rothstein,Mark A .
TI  - Pharmacogenomics: social, ethical, and clinical dimensions 
SN  - 0471227692
PY  - 2003///
CY  - Hoboken, N.J.
PB  - Wiley-Liss
KW  - Pharmacogenetics
KW  - Drug design
KW  - Ethics, Medical
KW  - Legislation, Medical
KW  - Public policy
KW  - Social environment
N1  - Public attitudes about pharmacogenomics / Mark A.        Rothstein and Carlton A. Hornung -- Pharmacogenomics:pharmacology and toxicology in the genomics era / Harvey  W. Mohrenweiser -- The implications of population genetics  for pharmacogenomics / Craig L.Hanis -- Genome research        and minorities / Henry T. Greely -- Drug development        strategies / Penelope K. Manasco and Teresa E. Arledge --        Drug development, regulation, and genetically guided        therapy / David W. Feigal and Steven I. Gutman --        Intellectual property and commercial aspects of        pharmacogenomics / Allen C. Nunnally, Scott A. Brown, and        Gary A. Cohen -- Integration of pharmacogenomics into        medical practice / Gilbert S. Omenn and Arno G. Motulsky -        - Clinical utility of pharmacogenetics and        pharmacogenomics / Neil A. Holtzman -- Medical liability        for pharmacogenomics -- Larry I. Palmer -- The challenges        of pharmacogenomics for pharmacy education / David B.        Brushwood -- Economic implications of pharmacogenomics /        C.E. Reeder and W. Michael Dickson -- Pharmacogenomics and        the social construction of identity / Morris W. Foster --        Pharmacogenomics: considerations for communities of color        / Laurie Nsiah-Jefferson -- Constitutional issues in the        use of pharmacogenomic variations associated with race /        John A. Robertson
ER  -